Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (4)

2019

  1. Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)

    Scientific Reports

  2. Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2009

  1. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer

    Carcinogenesis, Vol. 30, Núm. 11, pp. 1903-1909

2008

  1. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer

    Cell Research, Vol. 18, Núm. 8, pp. 823-833